General form of registration statement for all companies including face-amount certificate companies

Consolidated Statements of Changes in Stockholders' (Deficit)

v3.20.4
Consolidated Statements of Changes in Stockholders' (Deficit) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning of the period at Sep. 30, 2018 $ 159,815 $ 35,517,491 $ (34,317,478) $ 1,359,828
Balance at the beginning of the period (in shares) at Sep. 30, 2018 159,815,013      
Net loss $ 0 0 (4,547,582) (4,547,582)
Issuance of common stock and warrants, net of financing costs $ 8,615 1,112,093 0 1,120,708
Issuance of common stock and warrants, net of financing costs (in shares) 8,615,384      
Shares issued for the exercise of stock options - cashless $ 477 (477) 0 0
Shares issued for the exercise of stock options - cashless (in shares) 477,269      
Shares issued for the exercise of stock options $ 88 32,312 0 32,400
Shares issued for the exercise of stock options (in shares) 87,567      
Issuance of restricted stock $ 3,517 (3,517) 0 0
Issuance of restricted stock (in shares) 3,517,000      
Issuance of restricted stock for services $ 100 42,900 0 43,000
Issuance of restricted stock for services (in shares) 100,000      
Stock based compensation expense $ 0 1,184,349 0 1,184,349
Balance at the ending of the period at Sep. 30, 2019 $ 172,612 37,885,151 (38,865,060) $ (807,297)
Balance at the ending of the period (in shares) at Sep. 30, 2019 172,612,233     173,577,233
Net loss $ 0 0 (1,659,754) $ (1,659,754)
Issuance of common stock and warrants, net of financing costs $ 14,286 2,152,876 0 2,167,162
Issuance of common stock and warrants, net of financing costs (in shares) 14,285,714      
Stock based compensation expense $ 0 199,052 0 199,052
Balance at the ending of the period at Dec. 31, 2019 $ 186,898 40,237,079 (40,524,814) (100,837)
Balance at the ending of the period (in shares) at Dec. 31, 2019 186,897,947      
Balance at the beginning of the period at Sep. 30, 2019 $ 172,612 37,885,151 (38,865,060) $ (807,297)
Balance at the beginning of the period (in shares) at Sep. 30, 2019 172,612,233     173,577,233
Net loss $ 0 0 (4,691,377) $ (4,691,377)
Issuance of common stock and warrants, net of financing costs $ 14,286 2,152,876 0 2,167,162
Issuance of common stock and warrants, net of financing costs (in shares) 14,285,714      
Issuance of restricted stock $ 965 (965) 0 0
Issuance of restricted stock (in shares) 965,000      
Stock based compensation expense $ 0 898,293 0 898,293
Balance at the ending of the period at Sep. 30, 2020 $ 193,045 41,862,901 (43,556,437) $ (1,500,491)
Balance at the ending of the period (in shares) at Sep. 30, 2020 193,044,766     193,044,766
Net loss $ 0 0 (1,154,104) $ (1,154,104)
Stock based compensation expense 0 85,611 0 85,611
Balance at the ending of the period at Dec. 31, 2020 $ 193,045 $ 41,948,512 $ (44,710,541) $ (2,568,984)
Balance at the ending of the period (in shares) at Dec. 31, 2020 193,044,766     193,094,766